Pilot Study of Abequolixron (RGX-104) and Durvalumab in Lung Cancer

Condition:   Non-Small Cell Lung Cancer Interventions:   Drug: Durvalumab;   Drug: Carboplatin;   Drug: Abequolixron;   Drug: Abraxane;   Drug: Pemetrexed Sponsors:   UNC Lineberger Comprehensive Cancer Center;   AstraZeneca;   Rgenix, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials